Indeed, we have previously shown that YY1 is able to enhance AP-2α, AP-2β, and AP-2γ transcriptional activity in vitro and that it is recruited via AP-2 to the ERBB2 endogenous promoter in a breast cancer cell line [16]. This evidence concerns the gene TFAP2B and breast carcinoma.